FDA warns of serious blood disorder resulting from abuse of Opana ER
FDA has warned patients of TTP, a serious blood disorder that results from misuse of Opana ER.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
